InsiderClue
← All stocks

Wave Life Sciences, Inc.

WVE Net buying
CIK 0001631574 #2524 in the set updated 17 Sep 2026
Bought (120 mo)
$166.66M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$58.80M
$6.13M on a plan · $37.39M straight out of an exercise
Sold at will
$15.28M
50 of 144 sales
Net
+$107.86M
+$151.38M against sales at will

By person

19 insiders · 166 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$99.89M (10)
—
+$99.89M
34,549,118
17.53%
$182.76M
+153.8%
GSK plc entity
10% owner
$66.77M (3)
—
+$66.77M
18,245,691
9.26%
$96.52M
+70.8%
BOLNO PAUL
President and CEO
—
$15.80M (30) scheduled
−$15.80M
275,520
0.1398%
$1.46M
+44.4%
Francis Chris
See Remarks
—
$15.78M (34) scheduled
−$15.78M
61,867
0.0314%
$327.28K
—
Tanaka Masaharu
Director
—
$11.31M (3)
−$11.31M
2,774,118
1.41%
$14.68M
−14.1%
Moran Kyle
Chief Financial Officer
—
$4.67M (14) scheduled
−$4.67M
134,385
0.0682%
$710.90K
+1,398%
Verdine Gregory L.
Director
—
$2.08M (9)
−$2.08M
275,217
0.1397%
$1.46M
+223.6%
Tan Aik Na
Director
—
$2.03M (11) scheduled
−$2.03M
24,968
0.0127%
$132.08K
—
Regnante Keith
Chief Financial Officer
—
$1.69M (3) scheduled
−$1.69M
29,186
0.0148%
$154.39K
—
Panzara Michael A.
See Remarks
—
$1.68M (11) scheduled
−$1.68M
109,103
0.0554%
$577.15K
+379.6%
HENRY CHRISTIAN O
Director
—
$1.56M (6) scheduled
−$1.56M
12,700
0.0064%
$67.18K
—
Vargeese Chandra
See Remarks
—
$879.54K (12) scheduled
−$879.54K
408,246
0.2072%
$2.16M
+1,438%
Rawcliffe Adrian
Director
—
$806.60K (3) scheduled
−$806.60K
0
0.0000%
$0.00
—
Wagner Heidi L
Director
—
$231.07K (3) scheduled
−$231.07K
44,930
0.0228%
$237.68K
—
CORRIGAN MARK
Director
—
$217.30K (2) scheduled
−$217.30K
28,815
0.0146%
$152.43K
—
TAKANASHI KEN
Director
—
$65.85K (2) scheduled
−$65.85K
9,626,487
4.89%
$50.92M
+68.7%
Gaiero David G
Interim CFO
—
$4.56K (1)
−$4.56K
6,392
0.0032%
$33.81K
−9.2%
Baldry Mark
Chief Commerical Officer
—
—
—
39,000
0.0198%
$206.31K
—
GUERCIOLINI ROBERTO
See Remarks
—
—
—
4,000
0.0020%
$21.16K
—

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Vargeese Chandra
9 Feb 2026
See Remarks
Sell
3,228
$13.45
$43.42K
Francis Chris
9 Feb 2026
See Remarks
Sell
1,883
$13.45
$25.33K
BOLNO PAUL
9 Feb 2026
President and CEO
Sell
10,480
$13.45
$140.96K
Moran Kyle
9 Feb 2026
Chief Financial Officer
Sell
3,588
$13.45
$48.26K
Moran Kyle
16 Feb 2023
Chief Financial Officer
Sell
9,729
$4.04
$39.31K
Francis Chris
16 Feb 2023
See Remarks
Sell
10,258
$4.03
$41.34K
BOLNO PAUL
16 Feb 2023
President and CEO
Sell
29,400
$4.04
$118.78K
Vargeese Chandra
16 Feb 2023
See Remarks
Sell
10,249
$4.03
$41.30K
Francis Chris
5 May 2022
See Remarks
Sell
10,867
$1.72
$18.69K
Panzara Michael A.
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Moran Kyle
5 May 2022
Chief Financial Officer
Sell
5,021
$1.72
$8.64K
BOLNO PAUL
5 May 2022
President and CEO
Sell
33,501
$1.72
$57.62K
Vargeese Chandra
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Panzara Michael A.
16 Feb 2022
See Remarks
Sell
10,603
$2.31
$24.49K
BOLNO PAUL
16 Feb 2022
President and CEO
Sell
33,150
$2.32
$76.91K
Vargeese Chandra
16 Feb 2022
Chief Technology Officer
Sell
10,603
$2.32
$24.60K
Francis Chris
16 Feb 2022
See Remarks
Sell
10,123
$2.31
$23.38K
Moran Kyle
16 Feb 2022
Chief Financial Officer
Sell
9,204
$2.31
$21.26K
Moran Kyle
16 Feb 2021
Chief Financial Officer
Sell
1,722
$10.57
$18.20K
Vargeese Chandra
16 Feb 2021
Chief Technology Officer
Sell
3,145
$10.57
$33.24K
Panzara Michael A.
16 Feb 2021
See Remarks
Sell
2,929
$10.57
$30.96K
BOLNO PAUL
16 Feb 2021
President and CEO
Sell
11,205
$10.57
$118.44K
Francis Chris
16 Feb 2021
See Remarks
Sell
2,698
$10.57
$28.52K
Vargeese Chandra
18 Feb 2020
Senior VP, Drug Discovery
Sell
3,188
$7.85
$25.03K
Francis Chris
18 Feb 2020
See Remarks
Sell
2,708
$7.85
$21.26K
BOLNO PAUL
18 Feb 2020
President and CEO
Sell
11,451
$7.85
$89.89K
Panzara Michael A.
18 Feb 2020
Chief Medical Officer
Sell
2,981
$7.85
$23.40K
Gaiero David G
3 Feb 2020
Interim CFO
Sell
651
$7.00
$4.56K
Verdine Gregory L.
20 Nov 2019
Director
Sell
2,609
$32.74
$85.42K
Verdine Gregory L.
20 Nov 2019
Director
Sell
3,400
$31.59
$107.41K
Verdine Gregory L.
20 Nov 2019
Director
Sell
24,030
$30.27
$727.39K
Panzara Michael A.
5 Jul 2019
Chief Medical Officer
Sell
445
$27.26
$12.13K
Panzara Michael A.
5 Jul 2019
Chief Medical Officer
Sell
2,613
$26.88
$70.24K
Panzara Michael A.
11 Mar 2019
Franchise Lead, Neurology
Sell
7,000
$48.00
$336.00K
Francis Chris
19 Feb 2019
See Remarks
Sell
1,709
$36.84
$62.96K
Vargeese Chandra
19 Feb 2019
Senior VP, Drug Discovery
Sell
2,055
$36.84
$75.71K
BOLNO PAUL
19 Feb 2019
President and CEO
Sell
119
$37.47
$4.46K
BOLNO PAUL
19 Feb 2019
President and CEO
Sell
7,614
$36.38
$277.00K
Panzara Michael A.
19 Feb 2019
Franchise Lead, Neurology
Sell
1,837
$36.84
$67.67K
Regnante Keith
19 Feb 2019
Chief Financial Officer
Sell
1,298
$36.84
$47.82K
Verdine Gregory L.
14 Nov 2018
Director
Sell
4,300
$39.52
$169.94K
Verdine Gregory L.
14 Nov 2018
Director
Sell
10,700
$38.59
$412.91K
Regnante Keith
16 Feb 2018
Chief Financial Officer
Sell
316
$51.85
$16.38K
Panzara Michael A.
16 Feb 2018
Franchise Lead, Neurology
Sell
511
$52.10
$26.62K
BOLNO PAUL
16 Feb 2018
President and CEO
Sell
2,200
$51.62
$113.56K
BOLNO PAUL
16 Feb 2018
President and CEO
Sell
514
$51.01
$26.22K
Tanaka Masaharu
18 Sep 2017
Director
Sell indirect
6,362
$24.19
$153.90K
Tanaka Masaharu
15 Sep 2017
Director
Sell indirect
14,385
$24.22
$348.40K
Panzara Michael A.
12 Jul 2017
Franchise Lead, Neurology
Sell
7,414
$16.67
$123.62K
Tanaka Masaharu
29 Mar 2017
Director
Sell indirect
433,825
$24.91
$10.81M
Show all 166 transactions →

What was left out

Form 4 filings counted 226
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,085,925
Sales filed before the plan box existed 46
History held since 14 Nov 2016